125 related articles for article (PubMed ID: 3311559)
1. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
Asakawa N; Saito Y; Yamasaki Y; Kawamori R; Shichiri M
Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
[TBL] [Abstract][Full Text] [Related]
2. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
3. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
[TBL] [Abstract][Full Text] [Related]
4. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
7. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
9. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas.
Yagi T; Yamasaki Y; Bando K; Kawamori R; Kamada T; Shichiri M
Med Prog Technol; 1988; 13(4):195-201. PubMed ID: 2972904
[TBL] [Abstract][Full Text] [Related]
11. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
[TBL] [Abstract][Full Text] [Related]
12. A semiclosed-loop algorithm for the control of blood glucose levels in diabetics.
Fisher ME
IEEE Trans Biomed Eng; 1991 Jan; 38(1):57-61. PubMed ID: 2026432
[TBL] [Abstract][Full Text] [Related]
13. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.
Panteleon AE; Loutseiko M; Steil GM; Rebrin K
Diabetes; 2006 Jul; 55(7):1995-2000. PubMed ID: 16804068
[TBL] [Abstract][Full Text] [Related]
15. The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis.
Goriya Y; Kawamori R; Shichiri M; Abe H
Med Prog Technol; 1979 Jun; 6(3):99-108. PubMed ID: 481366
[TBL] [Abstract][Full Text] [Related]
16. An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control.
Ward WK; Wood MD; Casey HM; Quinn MJ; Federiuk IF
Artif Organs; 2005 Feb; 29(2):131-43. PubMed ID: 15670282
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
Buysschaert M; Lejeune M; Lambert AE
Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
[TBL] [Abstract][Full Text] [Related]
18. A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.
Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Gómez EJ; Hernando ME
Diabetes Technol Ther; 2010 Feb; 12(2):95-104. PubMed ID: 20105038
[TBL] [Abstract][Full Text] [Related]
19. Neural predictive controller for insulin delivery using the subcutaneous route.
Trajanoski Z; Wach P
IEEE Trans Biomed Eng; 1998 Sep; 45(9):1122-34. PubMed ID: 9735562
[TBL] [Abstract][Full Text] [Related]
20. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
Ratzmann KP; Jutzi E; Albrecht G
Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
